These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34040940)

  • 21. The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport.
    Nasi M; Patrizi G; Pizzi C; Landolfo M; Boriani G; Dei Cas A; Cicero AFG; Fogacci F; Rapezzi C; Sisca G; Capucci A; Vitolo M; Galiè N; Borghi C; Berrettini U; Piepoli M; Mattioli AV
    J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):631-639. PubMed ID: 31436678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowledge Gaps in Cardiovascular Care of Older Adults: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society: Executive Summary.
    Rich MW; Chyun DA; Skolnick AH; Alexander KP; Forman DE; Kitzman DW; Maurer MS; McClurken JB; Resnick BM; Shen WK; Tirschwell DL
    J Am Geriatr Soc; 2016 Nov; 64(11):2185-2192. PubMed ID: 27673575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines.
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR; ;
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):913-9. PubMed ID: 25443815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study.
    Galderisi S; De Hert M; Del Prato S; Fagiolini A; Gorwood P; Leucht S; Maggioni AP; Mucci A; Arango C
    Eur Psychiatry; 2021 Jan; 64(1):e7. PubMed ID: 33413701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology Position Statement on Dyslipidemia Management. Differences Between the European and American Guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Hipertens Riesgo Vasc; 2015; 32(2):83-91. PubMed ID: 26179969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INTERASPIRE: an International Survey of Coronary Patients; Their Cardiometabolic, Renal and Biomarker Status; and the Quality of Preventive Care Delivered in All WHO Regions : In Partnership with the World Heart Federation, European Society of Cardiology, Asia Pacific Society of Cardiology, InterAmerican Society of Cardiology, and PanAfrican Society of Cardiology.
    McEvoy JW; Jennings C; Kotseva K; De Backer G; De Bacquer D; Erlund I; Lip GYH; Ray KK; Rydén L; Adamska A; Wood DA
    Curr Cardiol Rep; 2021 Aug; 23(10):136. PubMed ID: 34410520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of m-Health Technology for Preventive Interventions to Tackle Cardiometabolic Conditions and Other Non-Communicable Diseases in Latin America- Challenges and Opportunities.
    Beratarrechea A; Diez-Canseco F; Irazola V; Miranda J; Ramirez-Zea M; Rubinstein A
    Prog Cardiovasc Dis; 2016; 58(6):661-73. PubMed ID: 27041078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Semergen; 2015 Apr; 41(3):149-57. PubMed ID: 25450438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Clin Investig Arterioscler; 2015; 27(1):36-44. PubMed ID: 25444651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latin American guidelines on hypertension. Latin American Expert Group.
    Sanchez RA; Ayala M; Baglivo H; Velazquez C; Burlando G; Kohlmann O; Jimenez J; Jaramillo PL; Brandao A; Valdes G; Alcocer L; Bendersky M; Ramirez AJ; Zanchetti A;
    J Hypertens; 2009 May; 27(5):905-22. PubMed ID: 19349909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology.
    Pedretti RFE; Hansen D; Ambrosetti M; Back M; Berger T; Ferreira MC; Cornelissen V; Davos CH; Doehner W; de Pablo Y Zarzosa C; Frederix I; Greco A; Kurpas D; Michal M; Osto E; Pedersen SS; Salvador RE; Simonenko M; Steca P; Thompson DR; Wilhelm M; Abreu A
    Eur J Prev Cardiol; 2023 Jan; 30(2):149-166. PubMed ID: 36098041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology.
    Piepoli MF; Corrà U; Adamopoulos S; Benzer W; Bjarnason-Wehrens B; Cupples M; Dendale P; Doherty P; Gaita D; Höfer S; McGee H; Mendes M; Niebauer J; Pogosova N; Garcia-Porrero E; Rauch B; Schmid JP; Giannuzzi P
    Eur J Prev Cardiol; 2014 Jun; 21(6):664-81. PubMed ID: 22718797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The ANMCO (National Association of Hospital Cardiologists) in a changing health care system. Consensus development of the Organizing Symposium of the XXXI National Congress of Cardiology--ANMCO; Florence, May 21, 2000].
    Ital Heart J Suppl; 2000 Dec; 1(12):1533-44. PubMed ID: 11221582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
    Brunzell JD; Davidson M; Furberg CD; Goldberg RB; Howard BV; Stein JH; Witztum JL; ;
    Diabetes Care; 2008 Apr; 31(4):811-22. PubMed ID: 18375431
    [No Abstract]   [Full Text] [Related]  

  • 36. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The U.S. prevention of cardiovascular disease guidelines and implications for implementation in LMIC.
    Wong ND; Moran AE
    Glob Heart; 2014 Dec; 9(4):445-55. PubMed ID: 25592799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.
    Gijón-Conde T; Sánchez-Martínez M; Graciani A; Cruz JJ; López-García E; Ortolá R; Rodríguez-Artalejo F; Banegas JR
    J Hypertens; 2019 Jul; 37(7):1393-1400. PubMed ID: 31145710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutrition and physical activity recommendations from the United States and European cardiovascular guidelines: a comparative review.
    Ferraro RA; Fischer NM; Xun H; Michos ED
    Curr Opin Cardiol; 2020 Sep; 35(5):508-516. PubMed ID: 32649350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.
    Lloyd-Jones DM; Morris PB; Ballantyne CM; Birtcher KK; Daly DD; DePalma SM; Minissian MB; Orringer CE; Smith SC
    J Am Coll Cardiol; 2017 Oct; 70(14):1785-1822. PubMed ID: 28886926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.